MONTREAL, QUEBEC--(Marketwire - October 02, 2008) - Adaltis Inc. (TSX: ADS) ("Adaltis"), an international in vitro diagnostic company, today announced changes to its Board of Directors. As agreed in connection with the issuance of senior secured convertible notes to Clarity China Partners and FMRC Family Trust announced on September 5, 2008, the Board of Directors has been reduced in size from eleven to seven members, and two representatives of Clarity Partners have been appointed to the Board.
